» Articles » PMID: 38347596

An Atlas of Cell-type-specific Interactome Networks Across 44 Human Tumor Types

Overview
Journal Genome Med
Publisher Biomed Central
Specialty Genetics
Date 2024 Feb 12
PMID 38347596
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Biological processes are controlled by groups of genes acting in concert. Investigating gene-gene interactions within different cell types can help researchers understand the regulatory mechanisms behind human complex diseases, such as tumors.

Methods: We collected extensive single-cell RNA-seq data from tumors, involving 563 patients with 44 different tumor types. Through our analysis, we identified various cell types in tumors and created an atlas of different immune cell subsets across different tumor types. Using the SCINET method, we reconstructed interactome networks specific to different cell types. Diverse functional data was then integrated to gain biological insights into the networks, including somatic mutation patterns and gene functional annotation. Additionally, genes with prognostic relevance within the networks were also identified. We also examined cell-cell communications to investigate how gene interactions modulate cell-cell interactions.

Results: We developed a data portal called CellNetdb for researchers to study cell-type-specific interactome networks. Our findings indicate that these networks can be used to identify genes with topological specificity in different cell types. We also found that prognostic genes can deconvolved into cell types through analyzing network connectivity. Additionally, we identified commonalities and differences in cell-type-specific networks across different tumor types. Our results suggest that these networks can be used to prioritize risk genes.

Conclusions: This study presented CellNetdb, a comprehensive repository featuring an atlas of cell-type-specific interactome networks across 44 human tumor types. The findings underscore the utility of these networks in delineating the intricacies of tumor microenvironments and advancing the understanding of molecular mechanisms underpinning human tumors.

Citing Articles

HCNetlas: A reference database of human cell type-specific gene networks to aid disease genetic analyses.

Yu J, Cha J, Koh G, Lee I PLoS Biol. 2025; 23(2):e3002702.

PMID: 39908239 PMC: 11798474. DOI: 10.1371/journal.pbio.3002702.


Considerations for building and using integrated single-cell atlases.

Hrovatin K, Sikkema L, Shitov V, Heimberg G, Shulman M, Oliver A Nat Methods. 2024; 22(1):41-57.

PMID: 39672979 DOI: 10.1038/s41592-024-02532-y.

References
1.
Lorenz U . SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev. 2009; 228(1):342-59. PMC: 2669678. DOI: 10.1111/j.1600-065X.2008.00760.x. View

2.
Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-Arnon L . Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019; 25(12):1916-1927. PMC: 6898788. DOI: 10.1038/s41591-019-0654-5. View

3.
Gide T, Quek C, Menzies A, Tasker A, Shang P, Holst J . Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. Cancer Cell. 2019; 35(2):238-255.e6. DOI: 10.1016/j.ccell.2019.01.003. View

4.
Huang J, Carlin D, Yu M, Zhang W, Kreisberg J, Tamayo P . Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst. 2018; 6(4):484-495.e5. PMC: 5920724. DOI: 10.1016/j.cels.2018.03.001. View

5.
Kuo Y, Zaidi S, Gornostaeva S, Komori T, Stein G, Castilla L . Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice. Blood. 2009; 113(14):3323-32. PMC: 2665897. DOI: 10.1182/blood-2008-06-162248. View